Intellijoint Surgical's Patent Portfolio Gains Strength Through the Issuance of New US Patents
(firmenpresse) - WATERLOO, ONTARIO -- (Marketwired) -- 11/04/15 -- , a privately held Canadian medical technology company committed to developing and commercializing low-cost miniaturized surgical smart tools, announced today that the United States Patent and Trademark Office has granted the company a key patent related to its core technology in miniature 3D surgical measurement. The patent, number 9138319, is entitled "Method and system for aligning a prosthesis during surgery".
Intellectual property development is a strategic cornerstone for Intellijoint Surgical. The company continues to build its patent portfolio through new applications and several recent issuances. The issuances include Intellijoint's core technology and the surrounding instrumentation enabling it to be placed in a sterile field. Another key patent, entitled "System and method for intra-operative leg position measurement" is expected to issue in early 2016.
"Our miniaturized smart tools are setting the new standard in 3D measurement for surgery," says Armen Bakirtzian, Chief Executive Officer of Intellijoint Surgical. "Patent issuances are rewarding milestones recognizing the novel technology our organization has created. We will continue to aggressively pursue patents to protect our innovations and build business value".
Intellijoint's technology provides quantifiable, accurate, intra-operative feedback helping surgeons and hospitals to potentially improve surgical outcomes through accurate implant positioning and selection, ultimately improving patient satisfaction and healthcare economics.
Intellijoint Surgical will be attending American Academy for Hip and Knee Surgeons Annual Meeting Nov 5-8, 2015 in Dallas, Texas and Current Concepts in Joint Replacement Dec 9-12, 2015 in Orlando, Florida to showcase their flagship product intellijoint HIP™ that has been used in over 250 surgeries across the US & Canada.
About Intellijoint Surgical Inc.
Intellijoint Surgical is a Waterloo-based innovative medical technology company. Founded in 2010, they develop and commercialize miniaturized surgical smart tools that enhance surgeon accuracy, increase hospital economic efficiencies, and improve patient outcomes. The company's R & D team is led by the former co-founder of Medtronic's computer assisted surgery division, and driven by a team of renowned orthopaedic surgeons: Drs. Allan Gross and David Backstein in Toronto, Dr. Wayne Paprosky in Chicago, Dr. Javad Parvizi in Philadelphia and Drs. Michael Cross and Ran Schwarzkopf in New York.
Contacts:
Armen Bakirtzian, MHSc. BASc.
Co-Founder and CEO
Intellijoint Surgical Inc.
519-342-3178 x2100 or Cell: 647-234-8160
226-317-0471 (FAX)
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 04.11.2015 - 12:16 Uhr
Sprache: Deutsch
News-ID 431838
Anzahl Zeichen: 0
contact information:
Town:
WATERLOO, ONTARIO
Kategorie:
Medical Devices
Diese Pressemitteilung wurde bisher 188 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Intellijoint Surgical's Patent Portfolio Gains Strength Through the Issuance of New US Patents"
steht unter der journalistisch-redaktionellen Verantwortung von
Intellijoint Surgical Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
